Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-06

Clinical Trial Update: A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351) [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety study of MK-0954A in patients with essential hypertension completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MK-0954A

Snippet

Sponsor: Organon and Co | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2014-01-06